Recently Published Data Demonstrate Benefits of CyberKnife Treatment for Both Low- and Intermediate-Risk Patients at Five Years Post-Treatment SUNNYVALE, Calif. , Sept. 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that published data from two prospective,
Adoption of Innovative Radiation Therapy Technology Reinforces South Asian Cancer Center's Position as Pioneer in Patient Care SUNNYVALE, Calif. , Oct. 4, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the clinical team at Healthcare Global Enterprises (HCG) EKO,
Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care SUNNYVALE, Calif. , Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the
SUNNYVALE, Calif. , Oct. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2018 on Tuesday, October 30, 2018 after the market close. Management will host a conference call to review the first quarter results at 1:30 p.m.
SUNNYVALE, Calif. , Oct. 17, 2018 /PRNewswire/ -- Building on its heritage of patient-first innovation, at this year's ASTRO ( American Society for Radiation Oncology ) Annual Meeting, Accuray Incorporated (NASDAQ: ARAY) will showcase radiation therapy solutions designed to enable clinicians to
SUNNYVALE, Calif. , Oct. 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2019 ended September 30, 2018 . Company Highlights China Ministry of Health confirms Type A and B quota and licenses Gross orders increased 10
SUNNYVALE, Calif. , Nov. 19, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately. Mr. Hamamatsu joined Accuray as its vice president of finance and
Next-Generation Accuray Precision® Treatment Planning System With the CyberKnife VOLO™ Optimizer Also Reduces Treatment Planning Times Up to 90 Percent, Enabling Clinicians to Treat More Patients Each Day SUNNYVALE, Calif. , Dec. 6, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY)
SUNNYVALE, Calif. , Jan. 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January 9, 2019 at the Westin St. Francis Hotel in San Francisco .
SUNNYVALE, Calif., Jan. 8, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2018 on Tuesday, January 22, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
